About this trial
Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.
Eastern Cooperative Oncology Group performance status of 0 or 1.
Adequate organ function.
Disqualifiers
Patients had distant metastasis.
oesophageal invasion of more than 3 cm.
Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.
Previous chemotherapy or radiation therapy for any other malignancies.
Trial design
Parallel
Treatments tested in this trial
Reduced port laparoscopic gastrectomy
Procedure/SurgeryThe ports were reduced in the surgery of intervention arm.
Treatment groups
Trial outcomes
Primary outcomes
5-year survival rate
Longterm survival for patients with gastrectomy after reduced port laparoscopic gastrectomy
3-year survival rate
Survival rate for patients with gastrectomy after reduced port laparoscopic gastrectomy
Secondary outcomes
Postoperative morbidity rate
Postoperative morbidity rate for patients with gastrectomy after reduced port laparoscopic gastrectomy
Malnutrition rate
Malnutrition rate for patients with gastrectomy after reduced port
Quality of life in PGSAS-45 scale
The quality of life were assessed using PGSAS-45 scale for patients with gastrectomy after reduced port laparoscopic gastrectomy.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.